CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-24 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Grant or award | +240,000 | 240,000 | ||
| 2023-08-24 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Grant or award · Option (right to buy) | +160,000 | 160,000 | ||
| 2023-08-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −23,304 | $21.51 | $501K | 585,496 |
| 2023-08-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −8,074 | $21.51 | $174K | 563,557 |
| 2023-08-15 | Hessekiel Jeffrey EVP, General Counsel & Sec | Shares withheld for taxes | −7,177 | $21.51 | $154K | 564,799 |
| 2023-08-15 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −7,177 | $21.51 | $154K | 278,290 |
| 2023-08-15 | Aftab Dana CSO/EVP Disc & Trans Research | Shares withheld for taxes | −6,280 | $21.51 | $135K | 404,543 |
| 2023-08-04 | Senner Christopher J. EVP and CFO | Option exercise | +60,000 | $14.74 | $884K | 631,631 |
| 2023-08-04 | Senner Christopher J. EVP and CFO | Sale | −60,000 | $20.68 | $1.2M | 571,631 |
| 2023-08-04 | Senner Christopher J. EVP and CFO | Option exercise · Option (right to buy) | −60,000 | 0 | ||
| 2023-08-03 | Senner Christopher J. EVP and CFO | Option exercise | +60,000 | $14.74 | $884K | 631,631 |
| 2023-08-03 | Senner Christopher J. EVP and CFO | Sale | −60,000 | $20.51 | $1.2M | 571,631 |
| 2023-08-03 | Senner Christopher J. EVP and CFO | Option exercise · Option (right to buy) | −60,000 | 60,000 | ||
| 2023-08-03 | Haley Patrick J. EVP, Commercial | Sale | −30,553 | $20.67 | $632K | 285,467 |
| 2023-08-01 | Hessekiel Jeffrey EVP, General Counsel & Sec | Option exercise 10b5-1 | +55,710 | $14.74 | $821K | 627,686 |
| 2023-08-01 | Hessekiel Jeffrey EVP, General Counsel & Sec | Sale 10b5-1 | −55,710 | $19.63 | $1.1M | 571,976 |
| 2023-08-01 | Hessekiel Jeffrey EVP, General Counsel & Sec | Option exercise · Option (right to buy) 10b5-1 | −55,710 | 0 | ||
| 2023-05-31 | Oliver Bob Director | Grant or award | +18,176 | 18,176 | ||
| 2023-05-31 | Oliver Bob Director | Grant or award · Option (right to buy) | +36,353 | 36,353 | ||
| 2023-05-31 | Heyman Tomas J. Director | Grant or award | +18,176 | 18,176 |
Page 19 of 20 · 381 trades